XML 161 R137.htm IDEA: XBRL DOCUMENT v3.22.2.2
Income Taxes - Summary of significant components of the Company's deferred income tax asset (liabilities) (Detail) - CAD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Reconciliation Of Changes In Deferred Tax Liability Asset [Line Items]              
Balance in beginning     $ (2,291,057) $ (4,168,905) $ (4,168,905) $ (3,854,615)  
Acquired in business combinations           (1,136,805)  
Recovery/ (expense) through earnings $ 591,418 $ 372,600 1,482,234 491,824 1,822,109 668,209 $ 2,692,313
Recovery/ (expense) through equity           24,000  
Recovery/ (expense) through OCI         55,739 130,306  
Balance in ending         (2,291,057) (4,168,905) (3,854,615)
Property, plant and equipment [member]              
Reconciliation Of Changes In Deferred Tax Liability Asset [Line Items]              
Balance in beginning     68,259 261,661 261,661    
Acquired in business combinations           (376)  
Recovery/ (expense) through earnings         (195,977) 263,436  
Recovery/ (expense) through OCI         2,575 (1,399)  
Balance in ending         68,259 261,661  
Intangible assets other than goodwill [member]              
Reconciliation Of Changes In Deferred Tax Liability Asset [Line Items]              
Balance in beginning     (3,523,184) (5,012,355) (5,012,355) (5,321,008)  
Acquired in business combinations           (1,136,429)  
Recovery/ (expense) through earnings         1,415,370 1,280,692  
Recovery/ (expense) through OCI         73,801 164,390  
Balance in ending         (3,523,184) (5,012,355) (5,321,008)
Loans And Accrued Liabilities [Member]              
Reconciliation Of Changes In Deferred Tax Liability Asset [Line Items]              
Balance in beginning     (245,012) (1,714,850) (1,714,850) (1,696,435)  
Recovery/ (expense) through earnings         1,471,654 (41,233)  
Recovery/ (expense) through equity           24,000  
Recovery/ (expense) through OCI         (1,816) (1,182)  
Balance in ending         (245,012) (1,714,850) (1,696,435)
Share Issuance Costs [Member]              
Reconciliation Of Changes In Deferred Tax Liability Asset [Line Items]              
Balance in beginning     52,920 27,453 27,453    
Recovery/ (expense) through earnings         25,467 27,453  
Balance in ending         52,920 27,453  
Foreign Exchange [Member]              
Reconciliation Of Changes In Deferred Tax Liability Asset [Line Items]              
Balance in beginning     (6,741) 0 0 (39,533)  
Recovery/ (expense) through earnings         (6,765) 39,533  
Recovery/ (expense) through OCI         24    
Balance in ending         (6,741) 0 (39,533)
Non-capital losses/net operating losses [Member]              
Reconciliation Of Changes In Deferred Tax Liability Asset [Line Items]              
Balance in beginning     $ 1,362,701 $ 2,269,186 2,269,186 3,202,361  
Recovery/ (expense) through earnings         (887,640) (901,672)  
Recovery/ (expense) through OCI         (18,845) (31,503)  
Balance in ending         $ 1,362,701 $ 2,269,186 $ 3,202,361